Identifying monoclonal gammopathy of undetermined significance from electronic health records

被引:0
作者
Tanenbaum, Hilary C. [1 ,2 ]
Birmann, Brenda M. [3 ]
Bertrand, Kimberly A. [4 ]
Teras, Lauren R. [5 ]
Krishnan, Amrita Y. [6 ]
Pourhassan, Hoda [6 ]
Goldsmith, Scott [6 ]
Cannavale, Kimberly [1 ]
Wang, Sophia S. [6 ]
Chao, Chun R. [1 ,7 ]
机构
[1] Kaiser Permanente Southern Calif, Dept Res & Evaluat, Pasadena, CA USA
[2] Embark Vet, Sci Res & Dev, Ithaca, NY USA
[3] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA USA
[4] Boston Univ, Slone Epidemiol Ctr, Boston, MA USA
[5] Amer Canc Soc, Intramural Res Dept, Atlanta, GA USA
[6] City Hope Med Ctr, Duarte, CA USA
[7] Kaiser Permanente Southern Calif, Dept Res & Evaluat, 100 S Los Robles,2nd Floor, Pasadena, CA 91101 USA
基金
美国国家卫生研究院;
关键词
case identification; diagnosis code; electronic health records; MGUS; monoclonal gammopathy of undetermined significance; DIAGNOSIS; RISK;
D O I
10.1002/cnr2.1755
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundMonoclonal gammopathy of undetermined significance (MGUS) precedes multiple myeloma (MM). Use of electronic health records may facilitate large-scale epidemiologic research to elucidate risk factors for the progression of MGUS to MM or other lymphoid malignancies. AimsWe evaluated the accuracy of an electronic health records-based approach for identifying clinically diagnosed MGUS cases for inclusion in studies of patient outcomes/ progression risk. Methods and ResultsData were retrieved from Kaiser Permanente Southern California's comprehensive electronic health records, which contain documentation of all outpatient and inpatient visits, laboratory tests, diagnosis codes and a cancer registry. We ascertained potential MGUS cases diagnosed between 2008 and 2014 using the presence of an MGUS ICD-9 diagnosis code (273.1). We initially excluded those diagnosed with MM within 6 months after MGUS diagnosis, then subsequently those with any lymphoid malignancy diagnosis from 2007 to 2014. We reviewed medical charts for 100 randomly selected potential cases for evidence of a physician diagnosis of MGUS, which served as our gold standard for case confirmation. To assess sensitivity, we also investigated the presence of the ICD-9 code in the records of 40 randomly selected and chart review-confirmed MGUS cases among patients with a laboratory report of elevated circulating monoclonal (M-) protein (a key test for MGUS diagnosis) and no subsequent lymphoid malignancy (as described above).The positive predictive value (PPV) for the ICD-9 code was 98%. All MGUS cases confirmed by chart review also had confirmatory laboratory test results. Of the confirmed cases first identified via M-protein test results, 88% also had the ICD-9 diagnosis code. ConclusionThe diagnosis code-based approach has excellent PPV and likely high sensitivity for detecting clinically diagnosed MGUS. The generalizability of this approach outside an integrated healthcare system warrants further evaluation.
引用
收藏
页数:8
相关论文
共 15 条
  • [1] Identifying monoclonal gammopathy of undetermined significance in electronic health data
    Epstein, Mara Meyer
    Saphirak, Cassandra
    Zhou, Yanhua
    LeBlanc, Candace
    Rosmarin, Alan G.
    Ash, Arlene
    Singh, Sonal
    Fisher, Kimberly
    Birmann, Brenda M.
    Gurwitz, Jerry H.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 (01) : 69 - 76
  • [2] Epstein MM., 2017, DETECTING CASES MONO
  • [3] Clinical prevalence (diagnosed cases) of monoclonal gammopathy of undetermined significance in the US: estimating the burden on health care
    Go, R. S.
    Swanson, K. M.
    Sangaralingham, L. R.
    Habermann, E. B.
    Shah, N. D.
    [J]. LEUKEMIA, 2016, 30 (06) : 1443 - 1446
  • [4] Gregersen Henrik, 2013, Clin Epidemiol, V5, P321, DOI 10.2147/CLEP.S50757
  • [5] Monoclonal IgM Gammopathy and Waldenstrm's Macroglobulinemia
    Grunenberg, Alexander
    Buske, Christian
    [J]. DEUTSCHES ARZTEBLATT INTERNATIONAL, 2017, 114 (44): : 745 - +
  • [6] Changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM)
    Ho, Matthew
    Patel, Ashish
    Goh, Chia Yin
    Moscvin, Maria
    Zhang, Li
    Bianchi, Giada
    [J]. LEUKEMIA, 2020, 34 (12) : 3111 - 3125
  • [7] Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study
    Kristinsson, Sigurdur Y.
    Tang, Min
    Pfeiffer, Ruth M.
    Bjorkholm, Magnus
    Goldin, Lynn R.
    Blimark, Cecilie
    Mellqvist, Ulf-Henrik
    Wahlin, Anders
    Turesson, Ingemar
    Landgren, Ola
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (06): : 854 - 858
  • [8] Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study
    Kristinsson, Sigurdur Y.
    Bjorkholm, Magnus
    Andersson, Therese M-L
    Eloranta, Sandra
    Dickman, Paul W.
    Goldin, Lynn R.
    Blimark, Cecilie
    Mellqvist, Ulf-Henrik
    Wahlin, Anders
    Turesson, Ingemar
    Landgren, Ola
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (12): : 1714 - 1720
  • [9] Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
    Kyle, R. A.
    Durie, B. G. M.
    Rajkumar, S. V.
    Landgren, O.
    Blade, J.
    Merlini, G.
    Kroeger, N.
    Einsele, H.
    Vesole, D. H.
    Dimopoulos, M.
    San Miguel, J.
    Avet-Loiseau, H.
    Hajek, R.
    Chen, W. M.
    Anderson, K. C.
    Ludwig, H.
    Sonneveld, P.
    Pavlovsky, S.
    Palumbo, A.
    Richardson, P. G.
    Barlogie, B.
    Greipp, P.
    Vescio, R.
    Turesson, I.
    Westin, J.
    Boccadoro, M.
    [J]. LEUKEMIA, 2010, 24 (06) : 1121 - 1127
  • [10] Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma
    Kyle, Robert A.
    Remstein, Ellen D.
    Therneau, Terry M.
    Dispenzieri, Angela
    Kurtin, Paul J.
    Hodnefield, Janice M.
    Larson, Dirk R.
    Plevak, Matthew F.
    Jelinek, Diane F.
    Fonseca, Rafael
    Melton, Lee Joseph, III
    Rajkumar, S. Vincent
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (25) : 2582 - 2590